Lipiodol Production Cost Reports

The report provides detailed analysis essential for establishing a lipiodol production plant. It encompasses all critical aspects necessary for lipiodol production, including the cost of lipiodol production, lipiodol plant cost, lipiodol production costs, and the overall lipiodol production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a lipiodol production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Lipiodol Market Analysis: Demand and Supply Analysis, and Sourcing

Lipiodol is the brand name of ethiodized oil, an oily iodinated contrast agent made from poppyseed oil. Each milliliter contains 480 mg of iodine, organically combined with ethyl esters of poppyseed oil fatty acids. Marcel Guerbet first made the oil in Paris in 1901, and Guerbet still sells it as Lipiodol. Doctors use it for lymphography, hysterosalpingography, and selective hepatic intra-arterial imaging and treatment of liver tumors. The generic name, brand name, and pharmacopeia name all refer to the same product.

Demand for lipiodol is driven mostly by liver cancer care. Interventional radiologists mix it with chemotherapy drugs for transarterial chemoembolization, known as TACE, in hepatocellular carcinoma. Liver cancer is common in China, Korea, Japan, and Southeast Asia, so Asia takes a large share of volume. Fertility clinics, lymphatic interventions, and glue embolization add steady smaller demand across Europe, North America, and Asia. Supply has long been concentrated. Guerbet was the main global source for decades, and its pricing and plant decisions shaped access in many countries. Chinese and Korean generics now add capacity in their home markets, while Indian & Chinese API manufacturers offer the oil to finished dose producers, distributors, and tender buyers. A lipiodol demand and supply analysis must weigh TACE case growth, iodine prices, poppyseed oil supply, sterile filling capacity, and national price controls. Buyers check iodine content, density, viscosity, free iodine, sterility, and endotoxins on receipt.

Summary of the Product, Grades, and Uses

Lipiodol is a mixture rather than a single compound. Its main components are ethyl monoiodostearate and ethyl diiodostearate, formed when iodine adds across the double bonds of the fatty acid esters. Poppyseed oil is rich in linoleic acid, which gives many double bonds to iodinate. The USP monograph calls for 35.2% to 38.9% organically combined iodine and a specific gravity of 1.280 to 1.293 at 15 degree Celsius. The US label gives a density of 1.28 g/cm³ & a viscosity of 34 to 70 mPa·s at 20 degree Celsius. The oil is pale yellow to amber, clear, and darkens with light and air. It does not mix with water, which is why it stays in place after injection and forms stable emulsions with drug solutions.

Lipiodol reaches the market in two main forms. The finished product is a sterile injection in 10 mL glass ampoules or vials, sold in Europe as Lipiodol Ultra Fluide. The active ingredient is also sold as ethiodized oil API to manufacturers of finished injections, with US Drug Master Files held by some Chinese and Indian producers. Buyers check iodine content, density, viscosity, acidity, free iodine, sterility, and bacterial endotoxins against the pharmacopeia.

Lipiodol is used mainly for its radiopacity and its oily nature. It shows up clearly on X-ray and CT, stays where it is placed, and mixes with drugs or glue. These traits support its uses in imaging, embolization, and iodine supplementation. Hospitals, imaging centers, fertility clinics & public health programs are the end buyers, and most of them buy through distributors, tenders, or group purchasing contracts.

Main End-Uses of Lipiodol

Liver cancer treatment is the main application of Lipiodol. During conventional transarterial chemoembolization (TACE), an anticancer drug such as doxorubicin is mixed with Lipiodol and injected into the artery supplying the tumor. The oil helps carry the drug into the tumor and remains visible on CT scans, making it easier for doctors to monitor treatment. In the US, the approved label covers selective injection into the hepatic arteries for imaging tumors in adults with known hepatocellular carcinoma. Hospitals mainly look for a reliable supply, consistent viscosity, and good emulsion stability. Since TACE may be repeated several times, a patient may require more than one ampoule during treatment.

Medical imaging and fertility care are other important uses. Lipiodol is used in lymphography to make lymph vessels and nodes visible, and it can also help treat lymphatic leaks. In hysterosalpingography, it is used to examine the uterus and fallopian tubes. Fertility clinics, gynecology units, and radiology departments usually place smaller but regular orders. A Cochrane review found that flushing the fallopian tubes with an oil-based contrast agent may improve pregnancy rates in couples with unexplained infertility, supporting its use in fertility care.

Other applications include embolization procedures and iodine supplementation. Interventional radiologists may mix Lipiodol with cyanoacrylate glue to slow its setting time and make the material visible during imaging. Iodized oil has also been given orally or by injection to prevent goiter in areas where iodine deficiency is common. The World Health Organization lists iodized oil among its essential medicines. Public health programs generally focus on affordability, shelf life, and ease of administration. Although glue embolization, treatment of lymphatic leaks, and fallopian tube flushing account for smaller volumes, these uses help maintain demand across different hospital departments.

Lipiodol Market Risks

Lipiodol carries market risk from its small number of suppliers. When one producer controls most supply, a plant problem or a pricing dispute can leave hospitals short. Korea faced such a dispute when Guerbet sought a large price rise, and the national price for a 10 mL ampoule was later raised to about 190,000 won from 52,560 won. Price controls in Asia, competition from Chinese and Korean generics, and new embolic products such as drug-eluting beads add pressure on margins. Iodine prices move with Chilean and Japanese output, energy costs, mining permits, and demand from other iodine users such as X-ray contrast media, disinfectants, and LCD films.

Lipiodol production carries its own risks because the product is an oily sterile injectable. Iodination must be complete and even, or the iodine content and stability drift. Free iodine, acidity, and color rise if the oil is exposed to light, heat, or air. Sterile filling of a viscous oil into ampoules needs careful control of filling speed, temperature, particulates, and seal quality. Most rejected lots trace back to off-spec iodine content, free iodine, high acidity, particulates, or sterility failures. A failed sterile lot is costly because the iodine and oil inside it cannot be recovered.

Lipiodol Production Process and Main Cost Drivers

The lipiodol production process runs from poppyseed oil refining through transesterification to ethyl esters, iodination with anhydrous hydrogen iodide, washing, purification, filtration, filling, sterilization, inspection, and packing.

1. By Iodination of Poppyseed Oil Fatty Acid Ethyl Esters: The main inputs are refined poppyseed oil, ethanol, a transesterification catalyst, iodine, a reagent to make anhydrous hydrogen iodide, wash water, filter aids, glass ampoules or vials & nitrogen.

Lipiodol production starts with refined poppyseed oil. The oil is transesterified with ethanol and a catalyst to give the ethyl esters of its fatty acids. Glycerol is separated, and the esters are washed, dried, filtered & checked for fatty acid profile, acid value, and water before iodination. Iodine is then converted to anhydrous hydrogen iodide, with published descriptions citing silylated reagents for this step. The hydrogen iodide reacts with the esters in an amount sized to add across the double bonds. This step decides the iodine content of the final oil. Reactor material, temperature, moisture, and hydrogen iodide feed rate all need tight control, since water and air cause side reactions and free iodine.

The crude iodinated esters are washed to remove free iodine, acids, and other byproducts. They are then dried, decolorized where needed, and filtered. QC covers iodine content, density, viscosity, acidity, free iodine, and identity. The approved oil is filtered and filled into amber glass ampoules or vials under nitrogen in a clean area, then sterilized and inspected. Labels and cartons protect the product from light. The US label calls for storage at 15 to 30 degree Celsius, protected from light, with the ampoule kept in its carton until use.

Main Factors Affecting Lipiodol Production Cost

Lipiodol production cost is mainly driven by iodine. Each kilogram of finished oil holds about 350 to 390 grams of iodine, so iodine is the largest raw material cost. Iodine prices follow output from Chile and Japan, which supply most of the world's iodine. Losses during hydrogen iodide generation, iodination, washing, and purification add to the iodine bill, so iodine recovery from wash streams has a direct effect on cost. Poppyseed oil is a smaller cost, but pharmaceutical-quality oil with low impurity levels is not cheap.

Sterile manufacturing, quality, and compliance make up the rest of lipiodol cost. Clean rooms, ampoule filling lines, sterilization, and visual inspection need trained staff and steady validation. Each lot needs chemical testing, sterility testing, and endotoxin testing before release. Stability programs, regulatory files, and inspections add fixed costs. Batch sizes are small, so fixed costs weigh heavily on each ampoule. Glass ampoules, amber vials, stoppers, labels, cartons & leaflets add packaging cost, and losses at filling and inspection raise the cost of each good unit.

Raw Materials for Lipiodol Production Plant and its Procurement

The main raw materials used to produce lipiodol are iodine and poppyseed oil. Iodine is sourced mainly from nitrate deposits in Chile and brine wells in Japan, and is supplied in grades such as resublimed iodine and iodine prills. Poppyseed oil is extracted from opium poppy seeds, which are also grown for food use in Europe, Turkey, and other regions. Other inputs include ethanol, catalysts, silylated reagents, and filter aids. Pharmaceutical packaging materials, such as glass ampoules, vials, rubber stoppers, and cartons, are also required.

Buying cheaper raw materials does not always reduce production costs. Iodine containing excess moisture or impurities can reduce the iodination yield and increase the amount of free iodine in the finished product. Poor-quality poppyseed oil may contain oxidized fats or pesticide residues, or have an unsuitable fatty acid profile. These factors can affect the reaction and the final iodine content. As a result, raw material quality, reaction control, and losses during sterile filling all influence the cost per ampoule.

Manufacturers generally work with approved iodine and poppyseed oil suppliers to maintain consistent quality. Each batch of poppyseed oil is tested for its fatty acid profile, iodine value, peroxide value, and residues. Iodine is checked for purity, moisture, heavy metals, and residue on evaporation. Since iodine prices can fluctuate sharply, long-term supply contracts and safety stocks help reduce the risk of shortages and sudden cost increases. Glass ampoules and vials are purchased from qualified pharmaceutical packaging suppliers and checked for hydrolytic resistance, dimensions, and visible defects.

Sustainability and Regulatory Requirements

Lipiodol production raises environmental concerns centered on iodine recovery, solvent use, and waste. Wash streams carry iodide and iodine, which can be recovered and recycled to cut costs and pollution. Ethanol and organic solvents are recovered by distillation. Glycerol from transesterification can be sold or used as fuel. Broken glass, rejected ampoules & lab waste need safe disposal. Clean rooms, sterilizers, and HVAC systems use a lot of energy, so efficient air handling, heat recovery & water reuse help cut the plant's footprint.

Regulatory obligations for lipiodol follow from its status as a sterile injectable drug. In the US, it is approved under an NDA with a boxed warning that limits use to intralymphatic, intrauterine, and selective hepatic intra-arterial routes. US, European & Chinese pharmacopeia standards set specifications for the oil. Sterile manufacturing must meet GMP rules, including EU Annex 1 for sterile products. In China, generic versions must pass consistency evaluation against the reference product. Labels must warn about embolism, hypersensitivity, and thyroid effects. Safety data sheets cover iodine and hydrogen iodide handling.

CAPEX and OPEX for a Lipiodol Production Plant

A lipiodol production plant requires both chemical processing equipment and a sterile filling facility. The main equipment includes oil storage tanks, a transesterification reactor, and an ethanol recovery still. The chemical processing section also needs a corrosion-resistant iodination reactor, hydrogen iodide generation equipment, and washing vessels. Purification is carried out using separators, dryers, decolorizing tanks, and filters. For filling, the plant requires clean rooms, an ampoule or vial filling line, a sterilizer, and inspection machines. The quality control laboratory needs equipment for iodine titration, density and viscosity measurement, sterility and endotoxin testing, and stability studies. The facility also needs separate areas for chemical processing, sterile operations, warehousing, and dark storage.

Lipiodol production costs depend mainly on the raw materials and the efficiency of each processing stage. Iodine is the largest variable expense, followed by poppyseed oil, ethanol, other reagents, and packaging materials. Quality testing, utilities, equipment maintenance, and transportation add to the operating cost. The final cost per ampoule depends largely on iodine prices, the yield from iodination, filling losses, and how efficiently the plant operates its production batches. The lipiodol plant setup cost depends on sterile suite size, filling line speed, ampoule versus vial format, and lab scope. On the running side, the biggest cost lines are iodine, sterile labor, testing, and validation. In line with basic industrial production economics, plants that fill other sterile injectables on the same line spread fixed cost better. Validation, media fills, environmental monitoring & annual product reviews add recurring costs that small producers often underestimate.

Plant Location and Investment Factors

A suitable location for a lipiodol plant should have experience in sterile injectable production and a well-established drug regulatory system. France, Canada, China, and South Korea have existing production or filling facilities. Easy access to iodine, pharmaceutical-grade poppyseed oil, and trained staff is also important. The site must meet GMP requirements and obtain the necessary permits for solvent handling and wastewater disposal. Being close to major liver cancer treatment markets in Asia can help reduce shipping costs and simplify supply to hospitals and tenders. A reliable supply of electricity, purified water, nitrogen, and steam is essential for both chemical processing and sterile filling.

One of the main decisions in a lipiodol production plant project report is whether to manufacture the active ingredient, fill the finished injection, or carry out both operations. Active ingredient production requires expertise in iodination, corrosion-resistant equipment, and iodine recovery systems. Filling the product requires a validated sterile line designed to handle viscous oil. Manufacturers must also choose their target markets, as each country has its own approval process and pricing requirements. As this lipiodol production plant report shows, for a new entrant, securing a dependable iodine supply and validating the sterile filling line are key priorities. Clinical bridging studies and comparisons with the reference product may also require considerable time and investment before the product can be launched.

Major Lipiodol Producing Regions

France is the historic center of lipiodol production, where Guerbet developed the product, and Simafex makes the active ingredient. Canada hosts the contract plant that fills Guerbet's US ampoules, which the FDA approved after a long supply gap. China has several domestic producers, led by Jiangsu Hengrui, whose poppyseed ethiodized oil injection serves TACE demand. Korea has a domestic generic from Dongkook Pharmaceutical. India hosts API suppliers with US Drug Master Files. Most volume moves to hospitals in Asia, Europe, and North America. Trade data rarely separates lipiodol from other contrast media, so volumes are tracked mainly through company reports, tender data, and hospital sales figures.

Key Lipiodol Producers

Guerbet

• French contrast media company and originator of Lipiodol, first made by Marcel Guerbet.
• Sells Lipiodol and Lipiodol Ultra Fluide in many countries, including the US.
• Uses contract sites in Canada and France for ampoule and vial filling.
• Competes on brand, clinical history & approvals across many markets.

Simafex

• French fine chemical maker listed on the US label as maker of the ethiodized oil active ingredient.
• Handles iodination chemistry for Guerbet's supply chain.
• Works to pharmaceutical GMP standards for API production.
• Competes on iodine chemistry know-how & long customer ties.

Jiangsu Hengrui Pharmaceuticals

• Chinese drug maker with an approved poppyseed ethiodized oil injection.
• Product covers iodine deficiency, lymphography, TACE & hysterosalpingography in China.
• First domestic version to pass China's generic consistency evaluation.
• Competes on price, local supply, and hospital reach.

Dongkook Pharmaceutical

• Korean drug maker with a strong share of the local contrast media market.
• Received Korean approval for a generic ethiodized oil injection.
• Gives Korean hospitals a domestic alternative to imported supply.
• Competes on local service & contrast media experience.

Shanghai Xudong Haipu Pharmaceutical

• Chinese drug maker named among approved iodinated oil injection producers in China.
• Supplies hospitals in the domestic market.
• Part of China's growing base of contrast agent makers.
• Competes on price and local distribution.

Shanghai Wonder Pharma

• Chinese producer of ethiodized oil API listed with a US Drug Master File.
• Supplies the active ingredient to finished dosage makers.
• Offers an alternative API source beyond France.
• Competes on price, with GMP status to be verified by buyers.